Orphan designation: Ganaxolone Treatment of tuberous sclerosis, 15/10/2021 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 5 June 2025 - 14:25

Orphan designation: Ganaxolone Treatment of tuberous sclerosis, 15/10/2021 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-21-2503

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters